Catalyst Wire Dossier Catalyst Wire Dossier

Sapablursen

sapablursen · Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sapablursen, covering 2025-02-18 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) [Phase 3]

See pricing